Patent · US Active

Engineered target specific base editors

US11834686B2 · kind B2 · utility

0Cited by

80References

8Claims

0Family size

Assignee

Sangamo Therapeutics, Inc. · US

Inventors

Friedrich Fauser · Karlsruhe, DE
Jeffrey C. Miller · Pleasanton, US
Edward J. Rebar · Richmond, US

Key dates

Filing date	Aug 20, 2019
Grant date	Dec 5, 2023
Priority date	—
Expiry date	Apr 22, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2800/80
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Described herein are DNA-editing complexes, particularly DNA-editing complexes that specifically alter a single base pair in target DNA sequence as well as methods of making and using these DNA-editing complexes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.